Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer treatment evolves.
|Articles|July 7, 2015
Sue Friedman Provides an Overview of the ABOUT Network
Author(s)Sue Friedman
Sue Friedman, discusses the ABOUT Network, which is the first-ever patient-powered research registry created and governed by and for people affected by hereditary breast and ovarian cancers.
Advertisement
Sue Friedman, Executive Director, FORCE (Facing Our Risk of Cancer Empowered), discusses the
Advertisement
Related to this article
Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
Nicole Doell, MSN, RN, of Sylvester explains how nurses can address breast cancer misinformation without judgment and share vetted resources.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Sylvester's Nicole Doell, MSN, RN, discusses how oncology nurses can support patients with breast cancer emotionally, from diagnosis to survivorship.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
2
How Oncology Nurses Can Overcome Common Barriers to Research
3
What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
4
Vicarious Trauma Affects Oncology Nurses in Every Care Setting
5